Top

Published in:

01-02-2014 | Editorial

Systemic therapy of renal cell carcinoma

Authors: Viktor Grünwald, Alain Ravaud

Published in: World Journal of Urology | Issue 1/2014

Excerpt

The first licensed targeted agents had access to the markets in Europe in 2006, which catalyzed a rapid development of such drugs in metastatic renal cell carcinoma (mRCC). In recent years, different tyrosine kinase inhibitors (TKI) were tested, exploiting the inhibition of neoangiogenesis in mRCC. Numerous studies later, the TKI hype is over and has ceased expectations regarding treatment outcome in mRCC. …

Title: Systemic therapy of renal cell carcinoma
Authors: Viktor Grünwald
Alain Ravaud
Publication date: 01-02-2014
Publisher: Springer Berlin Heidelberg
Published in: World Journal of Urology / Issue 1/2014
Print ISSN: 0724-4983
Electronic ISSN: 1433-8726
DOI: https://doi.org/10.1007/s00345-013-1226-9

At a glance: The STEP trials

Springer Medicine

Systemic therapy of renal cell carcinoma

Excerpt

At a glance: The STEP trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2014

Quantifying subjective assessment of sleep quality, quality of life and depressed mood in children with enuresis

The role of functional imaging in the era of targeted therapy of renal cell carcinoma

Urinary functional outcomes in female neobladder patients

Robotic-assisted laparoendoscopic single-site radical nephrectomy: first experience with the novel Da Vinci single-site platform

Extracting data from electronic medical records: validation of a natural language processing program to assess prostate biopsy results

Malondialdehyde and CA II autoantibody levels are elevated in children with undescended testes